Therapeutic Drug Targets and Phytomedicine for Triple Negative Breast Cancer
Triple negative breast cancers (TNBC) are a biologically aggressiveform of breast cancer and constitute approximately 10-15% of all breast cancerpatients. Distant metastasis, lack of clinically targeted therapies andprognostic markers, makes the disease difficult to treat. Till now not muchwork has...
| 主要作者: | |
|---|---|
| 格式: | Licensed eBooks |
| 語言: | 英语 |
| 出版: |
Sharjah :
Bentham Science Publishers,
2023.
|
| 在線閱讀: | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3541987 |
書本目錄:
- Cover
- Title
- Copyright
- End User License Agreement
- Contents
- Foreword
- Preface
- List of Contributors
- Etiological Insights into TNBC and their Related Catastrophic Risks
- Haritha H Nair1 and Ruby John Anto1,*
- INTRODUCTION
- Epigenetic Profiling of Triple Negative Breast Cancer
- DNA Methylation Altering Triple Negative Breast Cancer Expression
- Histone Modification Altering Triple Negative Breast Cancer
- miRNA Altering Triple Negative Breast Cancer
- Long Non-coding RNA Signature Altering Triple Negative Breast Cancer Expression
- An Insight of Molecular Characterization of Triple Negative Breast Cancer
- MOLECULAR CLASSIFICATION OF TRIPLE NEGATIVE BREAST CANCER
- Basal Like (BL1 & BL2) Subtype of Triple Negative Breast Cancer
- Immunomodulatory Subtype of Triple Negative Breast Cancer
- Mesenchymal and Mesenchymal Stem Like Subtype of Triple Negative Breast Cancer
- Luminal Androgen Receptor Subtype of Triple Negative Breast Cancer
- Claudin Low Subtype of Triple Negative Breast Cancer
- HETEROGENEOUS NATURE OF TRIPLE NEGATIVE BREAST CANCER: A STUMBLING BLOCK
- POSSIBILITY OF SURVIVAL IN TRIPLE NEGATIVE BREAST CANCER
- UPDATES OF TRIPLE NEGATIVE BREAST CANCER ACROSS THE GLOBE
- Prevalence of Triple Negative Breast Cancer Amongst Barbadian Women
- Prevalence of Triple Negative Breast Cancer Amongst African Women
- Prevalence of Triple Negative Breast Cancer Amongst Oman Women
- Prevalence of Triple Negative Breast Cancer Amongst New Zealand Women
- CONCLUSION
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- ABBREVIATIONS
- REFERENCES
- A Clinical Cognizance of Molecular and Pathological Diagnostic Approach of TNBC
- Acharya Balkrishna1,2, Usman Umar Zango3, Saima Kauser Nasir4 and Vedpriya Arya1,*
- INTRODUCTION
- CLINICO-PATHOLOGICAL CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER
- Immunohistochemistry of Triple Negative Breast Cancer
- GENOMIC CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER
- Analysis of Emerging Mutations in Triple Negative Breast Cancer
- Biology of Circulating Tumor DNA and its Implication in Characterization of Triple Negative Breast Cancer
- PROTEOMIC CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER
- TRANSCRIPTOMIC ANALYSIS OF TRIPLE NEGATIVE BREAST CANCER
- RADIOLOGICAL CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER
- MRI Analysis of Triple Negative Breast Cancer
- Mammography of Triple Negative Breast Cancer
- CONCLUSION
- CONSENT FOR PUBLICATION
- CONFLICT OF INTEREST
- ACKNOWLEDGEMENTS
- ABBREVIATIONS
- REFERENCES
- Molecular Sub-Typing and Exploration of Key Signalling Pathways Involved in Complicating the Disease
- Nikhil Ponnoor Anto1, Amitha Muraleedharan2 and Rashmi Mittal3,*
- INTRODUCTION
- Aetiology of Triple Negative Breast Cancer Subtypes